Trial record 1 of 44 for:    predictive marker pet
Previous Study | Return to List | Next Study

Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer

This study has been completed.
Sponsor:
Collaborator:
Novartis
Information provided by:
University of Chicago
ClinicalTrials.gov Identifier:
NCT00529802
First received: September 12, 2007
Last updated: August 12, 2010
Last verified: August 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)